Event Type
Disclosure
Voluntary
Variant
8-K
and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or oth
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Company Presentation. 104 The cover page from Aclaris Therapeutics, In